1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RGCC CTRPv2 pan-cancer AAC -0.087 0.01
mRNA KCTD6 CTRPv2 pan-cancer AAC -0.093 0.01
mRNA FXYD5 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA NABP2 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA P2RX3 CTRPv2 pan-cancer AAC 0.12 0.01
mRNA GLT8D2 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA STK10 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA IL12RB2 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA WTIP CTRPv2 pan-cancer AAC -0.098 0.01
mRNA JPH2 CTRPv2 pan-cancer AAC -0.092 0.01
Download CSV